Table 5 Multivariate analysis of different prognostic variables in DSS and RFS of NCL-HCC patients using the Cox proportional hazard model.

From: Clinicopathological and prognostic significance of PKM2 protein expression in cirrhotic hepatocellular carcinoma and non-cirrhotic hepatocellular carcinoma

Variables

DSS

RFS

HR

95%CI

P value

HR

95%CI

P value

Model 1

AFP(ng/ml)

≤20/>20

0.817

0.311–2.148

0.682

0.851

0.323–2.236

0.743

HBsAg

yes/no

0.956

0.127–7.221

0.966

0.961

0.127–7.529

0.970

Model 2

AFP(ng/ml)

≤20/>20

0.875

0.331–2.313

0.788

0.935

0.354–2.471

0.892

HBsAg

yes/no

0.634

0.080–4.994

0.665

0.638

0.081–5.025

0.669

PKM2 expression

low/high

3.960

1.464–10.712

0.007

3.812

1.417–10.254

0.008

Model 3

AFP(ng/ml)

≤20/>20

0.627

0.217–1.815

0.390

0.862

0.298–2.494

0.784

HBsAg

yes/no

0.247

0.025–2.422

0.230

0.306

0.032–2.932

0.304

Tumor size (cm)

≤5/>5

3.734

1.160–12.020

0.027

2.904

0.899–4.381

0.045

Intrahepatic Metastasis

yes/no

5.832

1.980–17.095

0.011

5.354

1.810–10.261

0.012

TNM stage

(I/II)/(III/VI)

1.260

0.487–1.776

0.016

2.276

1.093–3.818

0.020

Vascular Invasion

yes/no

1.108

0.217–1.676

0.017

1.312

1.021–3.819

0.030

Tumor Differentiation

Poor/well

2.387

1.302–2.406

0.033

1.891

1.520–3.845

0.028

PKM2 expression

low/high

4.857

1.534–15.375

0.007

3.996

1.314–12.154

0.015

  1. Abbreviations: 95% CI = 95% confidence interval; HR = hazard ratio; TNM stage = tumour node metastasis; P-value < 0.05.